Print

Print


Annals of Neurology presents a supplement (2000;47(suppl. 1)) on
dyskinesias in Parkinson's disease. The contents are below.


Levodopa-induced dyskinesias - Foreword
CW Olanow, J Obeso, P Jenner

The spectrum of levodopa-induced dyskinesias
S Fahn

Dopamine receptors and locomotor responses: Molecular aspects
SC Sealfon

Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease:
Problems with the current model
JA Obeso, MC RodriguezOroz, M Rodriguez, MR DeLong, CW Olanow

Physiologic basis of dyskinesia
M Filion

Dopamine-mediated gene regulation in models of Parkinson's disease
CR Gerfen

Patterns of gene expression and behavior induced by chronic dopamine
treatments
JJ Canales, AM Graybiel

Levodopa-induced dyskinesia: A pathological form of striatal synaptic
plasticity?
P Calabresi, P Giacomini, D Centonze, G Bernardi

Molecular basis of levodopa-induced dyskinesias
F Calon, R Grondin, M Morissette, M Goulet, PJ Blanchet, T DiPaolo, PJ
Bedard

Investigating levodopa-induced dyskinesias in the Parkinsonian primate
JW Langston, M Quik, G Petzinger, M Jakowec, DA DiMonte

Factors influencing the onset and persistence of dyskinesia in
MPTP-treated primates
P Jenner

The neural mechanisms underlying levodopa-induced dyskinesia in
Parkinson's disease
JM Brotchie

Nigrostriatal system plasticity in Parkinson's disease: Effect of
dopaminergic denervation and treatment
EC Hirsch

Striatal mechanisms and pathogenesis of parkinsonian signs and motor
complications
TN Chase, JD Oh

Physiology of hypokinetic and hyperkinetic movement disorders: Model for
dyskinesia
JL Vitek, M Giroux

Neuronal recordings in Parkinson's disease patients with dyskinesias
induced by apomorphine
AM Lozano, AE Lang, R Levy, W Hutchison, J Dostrovsky

Clinical physiology of dopa dyskinesia
M Hallett

Neuroimaging of dyskinesia
DJ Brooks, P Piccini, N Turjanski, M Samuel
PMID: 10762143, UI: 20222797

Clinical pharmacology of levodopa-induced dyskinesia
JG Nutt
PMID: 10762144, UI: 20222798

Preventing levodopa-induced dyskinesias
CW Olanow, JA Obeso
PMID: 10762145, UI: 20222799

Medical treatment of levodopa-induced dyskinesias
O Rascol
PMID: 10762146, UI: 20222800

Dyskinesias and the subthalamic nucleus
AL Benabid, A Benazzouz, P Limousin, A Koudsie, P Krack, B Piallat, P Pollak
PMID: 10762147, UI: 20222801

Surgery for levodopa-induced dyskinesias
AE Lang

Copyright 2000 WE MOVE
Editor: Richard Robinson ([log in to unmask])

This service is provided free of charge to the Internet community,
courtesy of WEMOVE.org. This document may be freely redistributed by
email only in its unedited form. We encourage you to share it with your
colleagues.

E-MOVE archives, plus information on subscribing, are
available at http://www.wemove.org/emove.
To unsubscribe, send an e-mail to [log in to unmask],
with "unsubscribe e-move" in the message body.

E-MOVE is a service of WE MOVE (Worldwide Education and Awareness for
Movement Disorders)
204 West 84th Street
New York, NY 10024

TEL 800-437-MOV2
TEL 212-241-8567
FAX 212-987-7363
http://www.wemove.org

janet paterson
53 now / 41 dx / 37 onset
613 256 8340 / PO Box 171 Almonte Ontario K0A 1A0 Canada
visit my website "a new voice" at: "http://www.geocities.com/janet313/"